This means your blood has more platelets than normal. Platelets help stop bleeding. A high platelet count can increase the risk of blood clots forming in your veins or arteries.
Every report comes from a Lived member, sent anonymously.
Have you tried Aspirin for High Platelet Count?
A high platelet count, called thrombocytosis, means a blood test shows more platelets than usual. Platelets are tiny blood cells made in the bone marrow. When a blood vessel is injured, they clump together to plug the leak and start a blood clot. Most people with a high count feel nothing unusual, and the finding often turns up on a routine blood test. The most important question is why the count is high. In most people, roughly 8 or 9 in 10, the bone marrow is responding to something else going on in the body, such as iron deficiency, an infection or inflammation. This is called reactive or secondary thrombocytosis, and the platelets themselves usually work normally. Less often, the bone marrow overproduces platelets on its own. This is essential thrombocythemia (also called primary thrombocythemia), an uncommon long-term blood disorder that carries a higher risk of blood clots and, less often, bleeding.
Reactive thrombocytosis has many possible causes. Iron-deficiency anemia is a common one. Infections and inflammatory conditions, such as inflammatory bowel disease, connective tissue disorders or tuberculosis, can also raise platelets. Some causes are temporary: the count can climb for a while during recovery from significant blood loss or an acute infection. People whose spleen has been removed often have higher counts, because the spleen normally stores a share of the body's platelets. Cancer is a less common but important cause. Lung, gastrointestinal, breast and ovarian cancers and lymphoma are among those linked to high platelet counts, and sometimes a high count is the first sign of the cancer. This is why a count that stays high without an obvious explanation is investigated rather than ignored. Essential thrombocythemia comes from changes in the genes that control how the bone marrow makes platelets, most often genes called JAK2, CALR or MPL. It is most common between ages 50 and 70 and is more common in women, but it can occur at any age.
Platelets are counted as part of a complete blood count (CBC), a routine blood test. A typical count is about 150,000 to 450,000 platelets per microliter of blood, and a count above 450,000 is considered high. Normal ranges vary slightly between laboratories, and a single high result is often repeated to see whether it persists. The next step is finding the cause. A clinician asks about recent illness, surgery, blood loss and symptoms, and examines for signs of clots, bleeding or an enlarged spleen. Blood tests that look for common causes, such as iron deficiency or inflammation, and a blood smear (blood cells examined under a microscope) help separate a reactive count from a bone marrow problem. Depending on the situation, further tests may look for an underlying illness, including cancer. If no other cause is found and the count stays high, a hematologist (blood specialist) may test the blood for JAK2, CALR and MPL gene changes and may recommend a bone marrow biopsy, in which a small sample of marrow is removed and examined. Diagnosing essential thrombocythemia also means ruling out related bone marrow disorders that can raise platelets.
For reactive thrombocytosis, treatment is aimed at the underlying cause, such as replacing iron, treating an infection or controlling inflammation. The platelet count generally comes back down as the cause is addressed. Because these platelets usually work normally and serious clots are uncommon, medicines or procedures to lower the count are usually not needed. Essential thrombocythemia cannot currently be cured, but treatment can lower the chance of blood clots, its main danger, and of other serious complications. The plan depends on clot risk, judged mainly by age (risk is higher after 60), whether a clot has happened before and whether a JAK2 gene change is present. Many people take low-dose aspirin, which makes platelets less likely to clump and form clots. Some people with no symptoms and low risk need only monitoring. People at higher risk, such as those who have already had a clot or who are over 60 with a JAK2 change, usually also take a medicine that lowers platelet production in the bone marrow. Hydroxyurea, a medicine also used for some cancers and sickle cell disease, and pegylated interferon, an injected medicine, are common first choices; interferon can cause flu-like symptoms and other side effects that some people find hard to tolerate. Anagrelide, a medicine that specifically lowers platelets, is mostly used when hydroxyurea does not work, and it can cause palpitations, fluid retention and headaches. In an emergency, such as a stroke caused by essential thrombocythemia, a procedure called plateletpheresis can lower the count quickly by filtering platelets out of the blood through an IV line.
Reactive thrombocytosis usually settles once its cause is treated, and a repeat blood count can confirm the number has come down. If the count stays high, the search for an explanation continues. Essential thrombocythemia is a long-term condition, but many people live with it for decades. Life expectancy is somewhat shorter than average, and the outlook depends a great deal on age at diagnosis: in a 2024 expert review, half of people were still living about 18 years after diagnosis overall, and more than 35 years for those diagnosed when younger. Some people notice symptoms from poor flow in small blood vessels, such as headaches, lightheadedness, or burning, red or numb hands and feet. Day-to-day care involves regular blood counts to check and adjust treatment, and attention to other things that raise clot risk, including smoking, high blood pressure and diabetes. Surgery and pregnancy both need planning with the care team, since essential thrombocythemia can raise the risk of clots and pregnancy complications. Over many years, a small number of people develop myelofibrosis (scarring of the bone marrow) or, rarely, acute myeloid leukemia, which is one reason a hematologist usually follows the condition long term.
Ask about follow-up if a blood test shows a high platelet count, especially if it stays high on repeat testing or you have symptoms that have not been explained. If you have a high platelet count, particularly from essential thrombocythemia, contact your care team right away about pain, swelling, tenderness or warmth in an arm or leg, which can signal a clot in a deep vein. Let them know about unusual bleeding, such as frequent nosebleeds, easy bruising, bleeding gums or blood in the stool. Call 911 for signs of a stroke, such as sudden face drooping, weakness or numbness on one side, or trouble speaking or seeing, and for chest pain or sudden shortness of breath, since these can mean a clot has reached the brain, heart or lungs.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with High Platelet Count is like, what's helped you, or ask the community a question.